| Income Statement |
| Total Revenue | 19.94M |
|
| Revenues (USD) | 19.94M |
| Cost of Revenue | 7.72M |
| Gross Profit | 12.22M |
| Operating Expenses | 13.94M |
| Research and Development Expense | 1.43M |
| Selling, General and Administrative Expense | 12.51M |
| Operating Income | -1.72M |
| Interest Expense | 1.20M |
| Net Income | -3.20M |
| Net Income Common Stock | -3.20M |
| Net Income Common Stock (USD) | -3.20M |
| Consolidated Income | -3.20M |
| Earnings per Basic Share | -0.13 |
| Earnings per Basic Share (USD) | -0.13 |
| Earnings per Diluted Share | -0.13 |
| Earning Before Interest & Taxes (EBIT) | -1.99M |
| Earning Before Interest & Taxes (USD) | -1.99M |
| Weighted Average Shares | 24.16M |
| Weighted Average Shares Diluted | 24.16M |
| Balance Sheet |
| Cash and Equivalents | 24.59M |
| Cash and Equivalents (USD) | 24.59M |
| Trade and Non-Trade Receivables | 12.41M |
| Current Assets | 42.86M |
| Property, Plant & Equipment Net | 8.52M |
| Total Assets | 51.94M |
| Debt Current | 2.59M |
| Total Debt | 27.66M |
| Current Liabilities | 13.46M |
| Debt Non-Current | 25.07M |
| Total Liabilities | 39.72M |
| Accumulated Retained Earnings (Deficit) | -321.44M |
| Shareholders Equity | 12.22M |
| Shareholders Equity (USD) | 12.22M |
| Assets Non-Current | 9.08M |
| Total Debt (USD) | 27.66M |
| Deferred Revenue | 1.49M |
| Liabilities Non-Current | 26.26M |
| Trade and Non-Trade Payables | 4.44M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 885.00K |
| Net Cash Flow from Financing | -370.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 3.08M |
| Capital Expenditure | -543.00K |
| Issuance (Repayment) of Debt Securities | -370.00K |
| Net Cash Flow from Investing | -543.00K |
| Net Cash Flow from Operations | 3.99M |
| Share Based Compensation | 980.00K |